查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
3D打印药品市场规模、份额和趋势分析报告：按技术（喷墨打印、Zipdose 技术、立体光刻）、应用（骨科、神经病学）、用途、地区、细分市场预测2022-2030
市场调查报告书
商品编码
1114023

3D打印药品市场规模、份额和趋势分析报告：按技术（喷墨打印、Zipdose 技术、立体光刻）、应用（骨科、神经病学）、用途、地区、细分市场预测2022-2030

3D Printed Drugs Market Size, Share & Trends Analysis Report By Technology (Inkjet Printing, Zipdose Technology, Stereolithography), By Application (Orthopedic, Neurology), By End-use, Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

3D 打印药品市场增长和趋势

根据 Grandview Research 的一份新报告，到 2030 年，全球 3D 打印药品市场预计将达到 2.6974 亿美元。

预计从 2022 年到 2030 年，市场将以 15.32% 的复合年增长率增长。慢性病患病率上升，加上全球吞嚥困难患者人数不断增加，预计将增加对快速溶解药物的需求并推动市场发展。例如，2022 年 4 月发表的一项研究报告称，在中风和衰老等情况下，口咽性吞嚥困难的患病率更高，在老年人中为 26.19%。

随着社会老龄化，对老年人易吞服药片的开发需求越来越大。 3D 打印的高溶解性、易于吞嚥的药物可以帮助吞嚥困难的老年人。此外，根据联合国的数据，到 2050 年，65 岁及以上的人口将达到 15 亿。因此，预计全球老龄化人口的增加将推动对易吞服药物的需求，从而推动市场增长。

其他因素，例如药品需求的快速增长、医疗保健技术的改进，以及政府对 3D 打印行业的关注和支出，都在推动市场的增长。例如，2022 年 3 月，赢创风险投资投资了总部位于内华达州的 Laxxon Medical，以生产 3D 打印平板电脑。后者公司开发了一种 3D 丝网印刷技术来生产结构化片剂，并随着时间的推移控制 API 的释放。预计这些投资将在未来几年补充市场增长。

预计 COVID-19 疫情将对市场增长产生积极影响。领先的製造公司已经推出了几台打印机，以帮助增加药品和其他所需产品的产量。因此，在 COVID-19 流行期间，这些技术的使用预计会增加。

预计对个性化医疗的不断增长的需求将在未来几年显着推动市场增长。预计在不久的将来，市场将呈指数级增长，因为药品的 3D 打印可以生产小批量的个性化药品，这些药品具有精心定制的形状、剂量和尺寸。此外，利用3D打印技术可以显着降低製造成本，有望进一步加大该领域的投资力度。

另一方面，这些药物的副作用、使用 3D 打印製造非法药物以及政府对 3D 打印产品缺乏监管限制了市场的增长。例如，2018 年 3 月，阿姆斯特丹警方因非法交易这些毒品而受到抨击。然而，提高对这些药物益处的认识，例如即时溶解、减少製造时间、减少浪费和易于按需製造，可能会为市场增长创造多种前景。

3D 打印药品市场报告亮点

就技术而言，Zipdose 细分市场在 3D 市场中占有最大份额。这是由于对在口腔中快速分散的快速溶解药物的需求不断增长，从而导致采用率增加和市场增长。

预计喷墨打印机细分市场在预测期内将出现良好增长。由于 3D 药物可以根据每位患者的需求进行定制，因此它们所帮助的患者数量远远超过批量生产的药物，预计未来几年对它们的需求将猛增。

从应用来看，神经领域在全球市场占有很大份额。这被认为是由于老年人口的比例越来越高，他们患神经系统疾病的风险很高，从而促进了市场的增长。

由于对个性化医疗的需求不断增长以及采用该技术的生物製药的成本效益利用，医院和诊所部分在 2021 年占最终用户的很大份额。

由于技术先进的医疗保健研究框架的可用性、高研发投资的存在以及该地区 3D 打印药物的开发，北美将在 2021 年主导全球市场。

由于慢性病患病率的上升和主要参与者的存在，预计亚太地区未来将显着增长。

主要市场参与者的示例包括 3D 打印机和製药机、Aprcia Pharmaceuticals、BV LLC、Hewlett Packard Caribe 等。

内容

第1章研究方法

  • 市场细分和范围
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库
    • Gvr 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算国别市场
  • 全球市场：CAGR 计算
  • 调查假设
  • 辅助信息列表
  • 主要信息列表
  • 目的
  • 缩写列表

第 2 章市场定义

第 3 章执行摘要

  • 市场概览

第 4 章全球 3D 打印药品市场变量、趋势和范围

  • 3D 打印药品市场的谱系展望
    • 母公司市场展望
  • 绘製渗透率和增长前景
  • 监管框架
  • 市场驱动因素分析
    • 越来越多地使用 3D 打印在医疗行业
    • 越来越多地采用个性化药物
    • 3D 打印在各行业的多种应用
    • 对速溶片的高需求
    • COVID-19 爆发
  • 市场约束分析
    • 3D 打印药品的限制
    • 政府对 3D 打印产品缺乏监管
  • 市场机会分析
    • 提高对 3D 打印技术的认识和采用
  • 波特五力分析
  • 管道分析

第 5 章 3D 打印市场 - 细分分析，按技术，2018-2030 年（百万美元）

  • 全球 3D 打印药品市场：技术波动分析
  • 喷墨打印
  • 熔融沈积建模
  • 立体光刻
  • ZipDose 技术

第 6 章 3D 打印药品市场 - 细分分析，按应用，2018-2030 年（百万美元）

  • 全球 3D 打印药品市场：应用波动分析
  • 骨科
  • 神经科
  • 牙科
  • 其他

第 7 章 3D 打印药品市场细分分析，按最终用户，2018-2030 年（百万美元）

  • 3D 打印药品市场：最终用户波动分析
  • 医院和诊所
  • 调查
  • 其他

第 8 章 3D 打印药品市场：- 细分分析，按地区，2018-2030 年（百万美元）

  • 3D 打印药品市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 9 章竞争格局

  • 上市公司
    • 公司市场分析
    • 竞争信息中心分析
    • 战略框架
  • 非上市公司
    • 主要初创企业/技术颠覆者/创新者列表
    • 本地网络地图
  • 公司简介
    • APRECIA PHARMACEUTICALS LLC
      • 公司简介
      • Aller Co., Ltd.
      • 财务表现
      • 产品基准
      • 战略举措
    • 扩展生物科学
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 比奥杜罗
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 亲和力疗法
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • OSMOTICA PHARMACEUTICALS
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • ACRUX
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 葛兰素史克公司
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 惠普加勒比
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 默克
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 循环製药
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 阿斯利康
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • FABRX LTD.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-951-6

3D Printed Drugs Market Growth & Trends:

The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.

An increase in the aging population has led to the growing demand for the development of easy-to-swallow pills for the elderly. The 3D printed highly soluble and easy-to-swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy-to-swallow drugs resulting in market growth.

Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The latter company has developed a 3D screen-printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.

The COVID-19 pandemic is anticipated to positively impact market growth. Several printers have been launched by the operating companies in the advanced manufacturing industry to help increase the manufacturing of medications and other necessary products. As a result, the usage of these technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medicine is expected to majorly drive market growth in the coming years. As 3D printing of pharmaceutical drugs can produce personalized medicine in small batches with carefully tailored shapes, dosages, and sizes, the market is anticipated to grow at an exponential rate in the near future. In addition, the use of 3D printing technology can significantly reduce manufacturing costs thus, further increasing investments in this space.

On the other hand, adverse effects from these drugs, the use of 3D printing to create illegal drugs, and a lack of government restrictions for 3D printed products are limiting the market's growth. For instance, in March 2018, a police case was filed in Amsterdam, for the illegal handling of these drugs. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

3D Printed Drugs Market Report Highlights:

  • By technology, the zip dose segment held the largest share of the 3D market. This is attributed to the increase in the requirement for rapid soluble drugs that disperse quickly in the mouth, which in turn is likely to increase the adoption and anticipate market growth.
  • The inkjet printer segment is expected to grow lucratively during the forecast period. Due to the 3D medications can be personalized to each patient's needs, assisting them far more than batch-produced medicines, their demand is expected to skyrocket in the coming years.
  • By application, the neurology segment held a larger share of the global market. This is attributed to an increase in the proportion of older people, which is at an increased risk of developing neurological disorders and hence, propelling the market growth.
  • By end-use, the hospitals & clinics segment held a larger share in 2021, owing to the growing demand for personalized medicines and the cost-effective use of bio-drugs employing this technology.
  • North America dominated the global market in 2021 due to the availability of technologically advanced healthcare research framework, the presence of high R&D investment, and the development of 3D printed drugs in the region.
  • The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of chronic diseases and the presence of key players.
  • A few of the key market players include 3D Printer Drug Machine, Aprecia Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global 3D Printed Drugs Market Variables, Trends, & Scope

  • 4.1 3D Printed Drugs Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Rising Usage Of 3D Printing In The Medical Industries
    • 4.4.2 Increasing Adoption Of Personalized Drugs
    • 4.4.3 Multiple Applications Of 3D Printing In Various Industries
    • 4.4.4 High Demand For Instantaneous Soluble Tablets
    • 4.4.5 Outbreak Of Covid-19
  • 4.5 Market Restraint Analysis
    • 4.5.1 Limitations Of 3D Printed Medicines
    • 4.5.2 Lack Of Government Regulations For 3D Printed Products
  • 4.6 Market Opportunity Analysis
    • 4.6.1 Rising Awareness And Adoption Of The 3D Printing Technology
  • 4.7 Porter's Five Forces Analysis
  • 4.8 Pipeline Analysis

Chapter 5 3D Printed Market - Segment Analysis, by technology, 2018 - 2030 (USD Million)

  • 5.1 Global 3D Printed Drugs Market: Technology Movement Analysis
  • 5.2 Inkjet Printing
    • 5.2.1 Inkjet Printing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Fused Deposition Modeling
    • 5.3.1 Fused Deposition Modeling Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Stereolithography
    • 5.4.1 Stereolithography Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 ZipDose Technology
    • 5.5.1 Zipdose Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 3D Printed Drugs Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Global 3D Printed Drugs Market: Application Movement Analysis
  • 6.2 Orthopedic
    • 6.2.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Neurology
    • 6.3.1 Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Dental
    • 6.4.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 3D Printed Drugs Market- Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 7.1 3D Printed Drugs Market: End-User Movement Analysis
  • 7.2 Hospitals & Clinics
    • 7.2.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Research Laboratories
    • 7.3.1 Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 3D Printed Drugs Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 3D Printed Drugs Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Public Companies
    • 9.1.1 Company Market Position Analysis
    • 9.1.2 Competitive Dashboard Analysis
    • 9.1.3 Strategic Framework
  • 9.2 Private Companies
    • 9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 9.2.2 Regional Network Map
  • 9.3 Company Profiles
    • 9.3.1 APRECIA PHARMACEUTICALS LLC
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Alere, Inc.
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product Benchmarking
      • 9.3.1.5 Strategic Initiatives
    • 9.3.2 EXTEND BIOSCIENCES
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 BIODURO
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Financial Performance
      • 9.3.3.3 Product Benchmarking
      • 9.3.3.4 Strategic Initiatives
    • 9.3.4 AFFINITY THERAPEUTICS
      • 9.3.4.1 Company Overview
      • 9.3.4.2 Financial Performance
      • 9.3.4.3 Product Benchmarking
      • 9.3.4.4 Strategic Initiatives
    • 9.3.5 OSMOTICA PHARMACEUTICALS
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product Benchmarking
      • 9.3.5.4 Strategic Initiatives
    • 9.3.6 ACRUX
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Financial Performance
      • 9.3.6.3 Product Benchmarking
      • 9.3.6.4 Strategic Initiatives
    • 9.3.7 GLAXOSMITHKLINE PLC
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product Benchmarking
      • 9.3.7.4 Strategic Initiatives
    • 9.3.8 HEWLETT PACKARD CARIBE
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product Benchmarking
      • 9.3.8.4 Strategic Initiatives
    • 9.3.9 MERCK
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product Benchmarking
      • 9.3.9.4 Strategic Initiatives
    • 9.3.10 CYCLE PHARMACEUTICALS
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product Benchmarking
      • 9.3.10.4 Strategic Initiatives
    • 9.3.11 ASTRAZENECA
      • 9.3.11.1 Company Overview
      • 9.3.11.2 Financial Performance
      • 9.3.11.3 Product Benchmarking
      • 9.3.11.4 Strategic Initiatives
    • 9.3.12 FABRX LTD.
      • 9.3.12.1 Company Overview
      • 9.3.12.2 Financial Performance
      • 9.3.12.3 Product Benchmarking
      • 9.3.12.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 Regulatory Framework
  • TABLE 3 Global 3D printed drugs market estimates and forecasts by technology, 2018 - 2030 (USD Million)
  • TABLE 4 Global 3D printed drugs market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • TABLE 5 3D printed drugs- Key market restraint
  • TABLE 6 Global 3D printed drugs inkjet printing market by region, 2018 - 2030 (USD Million)
  • TABLE 7 Global 3D printed drugs fused deposition modeling market by region, 2018 - 2030 (USD Million)
  • TABLE 8 Global 3D printed drugs stereolithography market by region, 2018 - 2030 (USD Million)
  • TABLE 9 Global 3D printed drugs ZipDose technology market by region, 2018 - 2030 (USD Million)
  • TABLE 10 Global 3D printed drugs demand in orthopedic by region, 2018 - 2030 (USD Million)
  • TABLE 11 Global 3D printed drugs demand in neurology by region, 2018 - 2030 (USD Million)
  • TABLE 12 Global 3D printed drugs demand in dental by region, 2018 - 2030 (USD Million)
  • TABLE 13 Global 3D printed drugs demand in other applications by region, 2018 - 2030 (USD Million)
  • TABLE 14 Global 3D printed drugs demand in hospitals & clinics by region, 2018 - 2030 (USD Million)
  • TABLE 15 Global 3D printed drugs demand in research laboratories by region, 2018 - 2030 (USD Million)
  • TABLE 16 Global 3D printed drugs demand in other end-use by region, 2018 - 2030 (USD Million)
  • TABLE 17 North America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 18 North America 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 19 North America 3D printed drugs market by end-use, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 21 U.S. 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 22 U.S. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 23 Canada 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 24 Canada 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 25 Canada 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 26 Europe 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 27 Europe 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 28 Europe 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 29 Germany 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 30 Germany 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 31 Germany 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 32 U.K. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 33 U.K. 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 34 U.K. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 35 France 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 36 France 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 37 France 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 38 Italy 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 39 Italy 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 41 Spain 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 42 Spain 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 43 Spain 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 47 China 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 48 China 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 49 China 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 50 India 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 51 India 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 52 India 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 53 Japan 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 54 Japan 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 55 Japan 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 56 South Korea 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 57 South Korea 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 58 South Korea 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 59 Latin America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 60 Latin America 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 61 Latin America 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 62 Brazil 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 63 Brazil 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 64 Brazil 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 65 Mexico 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 66 Mexico 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 67 Mexico 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 68 MEA 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 69 MEA 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 70 MEA 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 71 South Africa 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 72 South Africa 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 73 South Africa 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 74 Saudi Arabia 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 75 Saudi Arabia 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 76 Saudi Arabia 3D printed drugs market by end-user, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 3D printed drugs market segmentation
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Market formulation & validation
  • FIG. 6 Commodity flow analysis
  • FIG. 7 3D printed drugs market snapshot (2021)
  • FIG. 8 Market segmentation
  • FIG. 9 Penetration & growth prospect mapping
  • FIG. 10 Consumer behavior analysis
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Porter's five forces analysis
  • FIG. 15 3D printed drugs market technology outlook: Segment dashboard
  • FIG. 16 3D printed drugs market: Technology movement analysis
  • FIG. 17 Inkjet printing market, 2018 - 2030 (USD Million)
  • FIG. 18 Fused deposition modeling market, 2018 - 2030 (USD Million)
  • FIG. 19 Stereolithography market, 2018 - 2030 (USD Million)
  • FIG. 20 ZipDose Technology market, 2018 - 2030 (USD Million)
  • FIG. 21 3D printed drugs market application outlook: Segment dashboard
  • FIG. 22 3D printed drugs market: Application movement analysis
  • FIG. 23 Orthopedic market, 2018 - 2030 (USD Million)
  • FIG. 24 Neurology market, 2018 - 2030 (USD Million)
  • FIG. 25 Dental market, 2018 - 2030 (USD Million)
  • FIG. 26 Other applications market, 2018 - 2030 (USD Million)
  • FIG. 27 3D printed drugs market end-user outlook: Segment dashboard
  • FIG. 28 3D printed drugs market: End-user movement analysis
  • FIG. 29 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • FIG. 30 Research laboratories market, 2018 - 2030 (USD Million)
  • FIG. 31 Other end-users market, 2018 - 2030 (USD Million)
  • FIG. 32 Regional market: Key takeaways
  • FIG. 33 Regional outlook, 2021 & 2030
  • FIG. 34 North America 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 35 U.S. 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 36 Canada 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 37 Europe 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 38 U.K. 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 39 Germany 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 40 France 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 41 Italy 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 42 Spain 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 43 Asia Pacific 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 44 Japan 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 45 China 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 46 India 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 47 South Korea 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 48 Latin America 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 49 Brazil 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 50 Mexico 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 51 MEA 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 52 South Africa 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 53 Saudi Arabia 3D printed drugs market, 2018 - 2030 (USD Million)